COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257510 | PMC |
| http://dx.doi.org/10.1016/j.hest.2023.06.001 | DOI Listing |
Publication Analysis
Top Keywords
intracerebral bleeding
8
special considerations
4
considerations pitfalls
4
pitfalls intracerebral
4
bleeding covid-19
4
covid-19 case
4
case treated
4
treated ecmo
4
ecmo covid-19
4
covid-19 coronavirus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!